[The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators].
Occhetta
E
E
Divisione Clinicizzata di Cardiologia, Facoltà degli Studi del Piemonte Orientale, Novara.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017147:Defibrillators, Implantable; D006801:Humans; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D017741:Survivors; D017180:Tachycardia, Ventricular / Q000401:mortality / Q000628:therapy*; D018487:Ventricular Dysfunction, Left / Q000401:mortality / Q000628:therapy*
D000889:Anti-Arrhythmia Agents